Timing of Second Generation ALK Inhibitors: First Line vs. Treatment after Acquired Resistance

from GRACEcast · host cancerGRACE Meetings

Dr. Ross Camidge, University of Colorado, addresses the question of whether to use a second generation ALK inhibitor as first line therapy or only after acquired resistance to crizotinib.

Episode metadata supplied by the publisher feed · Published Apr 13, 2016

Embed this episode

Attribution link and audio player

NOW PLAYING

Timing of Second Generation ALK Inhibitors: First Line vs. Treatment after Acquired Resistance

0:00 2:20

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

GRACEcast Radiation Oncology Video cancerGRACE - H. Jack West, MD Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care. GRACEcast - Discussions with the Global Resource for Advancing Cancer Education cancerGRACE In this podcast series, the Global Resource for Advancing Cancer Education (GRACE) works to bring professionals together with patients and caregivers to work in partnership. We interview patients, advocates and healthcare professionals to provide the most updated information for our community and to highlight important issues facing those dealing with a cancer diagnosis. For more information visit www.cancerGRACE.org. To join the conversation, visit https://cancergrace.org/forums GRACEcast Lung Cancer Audio cancerGRACE - H. Jack West, MD Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care. GRACEcast Lung Cancer Video cancerGRACE - H. Jack West, MD Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.

Frequently Asked Questions

How long is this episode of GRACEcast?

This episode is 2 minutes long.

When was this GRACEcast episode published?

This episode was published on April 13, 2016.

Can I download this GRACEcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!